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A single injection of lipopolysaccharide (LPS)' from gram-negative bacteria
can produce multiple pathophysiological changes. These include hypotension
(1-5), disseminated intravascular coagulation (DIC) (2,3,6-9,10), and changes in
numbers of peripheral blood cells (2-4,11) . The effector mechanisms responsible
for these complex phenomena are not well understood . What is known is that a
variety of humoral and cellular mediation systems may be activated by LPS in
experimental animals and in in vitro systems . For example, LPS has been
shown to activate both the classical and alternative pathways of complement
(12,13-17) Hageman factor (18), induce release of vasoactive and coagulation
promoting substances from platelets (11,19,20), damage endothelial cells (21-
23), and promote the release of effector substances from neutrophils (24), mono-
nuclear cells (25), and macrophages (26) .
The following studies were undertaken to establish the role of one of the
mediation systems, the complement system, in LPS-induced pathophysiologic
changes . We have assessed the role ofcomplement in LPS-induced hypotension
and DIC by different means . One approach has involved a comparison of the
results of LPS injection into normal rabbits with rabbits either depleted of C3
and terminal complement components by cobra factor or rabbits genetically
deficient in the sixth component ofcomplement . In these experiments the role of
the anaphylotoxins, as well as complement-mediated cell lysis, could be studied.
A second approach and one unique to this work involved the use of highly
purified, structurally defined LPS preparations which differ significantly in
' This is publication number 1033 from the Department of Immunopathology, Scripps Clinic
and Research Foundation, La Jolla, Calif, This work was supported by United States Public
Health Service Grant Al-07007 and National Heart and Lung Institute Program Project Number
16411 .
$ Recipient of United States Public Health Service Young Investigation Pulmonary Research
Grant HL18376-O1 .
§ Recipient of United States Public Health Service Research Career DevelopmentAward 1 K04
A100081-O1 .
' Abbreviations used in this paper: CoF, cobra venom factor ; DIC, disseminated intravascular
coagulation ; LPS, lipopolysaccharide .
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their ability to reduce the hemolytic complement levels ofnormal rabbit serum .
LPS was purified from Escherichia coli 0111 :84 and Salmonella minnesota
Re595 . When tested in vitro 250 Wg of0111 :134 LPS did not reduce the hemolytic
complement activity of normal rabbit serum . In contrast as little as 1 NAg of
Re595 LPS was shown to reduce complement levels in normal rabbit serum (D .
C . Morrison, personal communication) .
A less purified, particulate preparation ofLPS from Serratia marcescens was
also used in some experiments . The use of this LPS preparation allowed direct
comparison of our data with those of other workers (3,4,11), as well as determin-
ing ifsoluble and particulate preparations ofLPS behave in a similarmanner .
Many of the pathophysiologic changes which occur in experimental animals
after LPS injection have also been observed in patients with gram-negative
bacteremia who develop septic shock (10,27) . The studies ofGuenter et al . (5)
have suggested that the injection of purifiedLPS preparations into experimental
animals represent a useful model for the study of the pathophysiologic changes
which occur in patients with gram-negative bacteremias . Thus, a definition of
the mechanism of LPS-induced hypotension, DIC, and peripheral blood cell
changes may help to define the mediation systems responsible for similar
changes in patients with gram-negative sepsis .
Materials and Methods
Rabbits . Male and female 2-2.5 kg New Zealand white rabbits from a closed colony and
rabbits genetically deficient in C6 bred into the same colony were obtained from Rancho de Conejo,
Vista, Calif. Animals had free access to food an water before the beginning ofthe experiment .
LPS .
￿
LPS was prepared from E . coli 0111:84 by phenol extraction and further purified by
treatment with ribonuclease, ethanol precipitation, and gel filtration (28) . LPS was also purified
from S . minnesota Re595% by the phenol-petroleum ether-chloroform procedure of Galanos et al .
(29) . Both LPS preparations were free of detectable protein and nucleic acid. LPS 0111 :114 was
soluble in aqueous solution and was stored at -70°C . Concentrations of 0111:84 LPS were
determined by measuring the colitose content ofthe purified material (28) . Lyophilized LPS Re595
was solubilized by the addition of 0.1% triethylamine followed by sonication . This material was
dialyzed against sterile isotonic saline before use . LPS isolated from S . marcescens was obtained
from Difco Laboratories, Detroit, Mich . and was used after suspending the lyophilized LPS in
sterile, isotonic saline followed by sonication .
Experimental Procedure .
￿
On the morning ofthe experiment a cannula (Intramedic Polypropyl-
ene Tubing, ID 0.023") was inserted into the femoral artery approximately to the level ofthe aortic
bifurcation . Surgery was performed after the subcutaneous administration of 1-2 ml of 1%
Novocain at the incision site . The animals were strapped in a supine position during surgery and
for the remainder of the experiment . The cannula was utilized to remove blood samples from
which cell counts and plasma protein concentrations were determined, as well as to measure blood
pressure . Blood pressures were measured with a Statham SP 1400 Blood Pressure Monitor
(Statham Instruments, Inc ., Oxnard, Calif .) and Statham P37B Pressure Transducer . Two pres-
sure measurements as well as 2.5-ml blood samples were taken 30-60 min before LPS injection to
establish preinjection base-line values for the various parameters measured during the experi-
ment . Data for all parameters measured is expressed as a percentage of the value determined
immediately preceding the LPS injection. Stable base-line values were obtained for all parameters
measured . After the injection of LPS, blood samples were removed at 5, 30, 50, 180, and 300 min
x The S . minnesota Re595 LPS was prepared while one of us (D . C . M .) was a guest in the
laboratory of Professor Otto Mideritz, Max Planck Instit fur Immunbiologie, Freiburg im Br .,
Germany .1572
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postinjection, while pressures were monitored at 5, 30, and every 30 min thereafter for the
remainderofthe experiment. Thecannula wasroutinelyflushedevery30 min with no more than 1
ml of a 2 U heparin/ml sterile saline.
In all experiments LPS wasinjected intravenously in a 1-ml volume during a 30-s time period.
Quantitation ofPeripheralBlood Cells.
￿
Bloodsamples were collected into 3.8% sodium citrate
(1 vol citrate/9 vol blood) in plastic tubes. Samples of anticoagulated blood were diluted in 2%
acetic acid and granulocytes and mononuclear cells counted in a hemocytometer.
Changes in circulating platelets were determined by injection of 5'Cr-platelets 18-24 h before
the beginningof the experiment. Therabbit bloodwas drawnthrough a 19 gaugeneedle from the
ear artery into plastic tubes with acid citrate dextrose (ACD) (30) (1 vol ACD/6 vol blood). The
sample was centrifuged 20 min x 1,500 rpm at 25°C (International PR-2, 12 place rotor), the
platelet-"rich" plasma aspirated and recentrifuged for 15 min at 25°C, 3,000 rpm, as above. The
platelet "poor" plasma wasremoved and the pellet wasresuspended in 1-2ml ofthe platelet poor
plasma. After incubation for 60 min at 37°C with "Cr (0.23 mCi/tube of whole blood originally
collected) the platelets were washed twicewith platelet poor plasma, resuspended in platelet poor
plasma, and injected into theexperimental rabbits. Radioactivity in 0.5-ml aliquots of wholeblood
was measured in a Packard Automatic gamma counter (Packard Instrument Co., Inc., Downers
Grove, Ill.) to quantitate changes in circulating platelets. Control experiments in normal, noncan-
nulatedrabbits demonstrated that "Cr-plateletshave ahalf-life (ta) of approximately30 h. When
experimental data determined over a5-hperiod from normal andcobra venom factor (CoF)-treated
rabbits (after cannulation) was compared to a calculated curve for "Cr platelet disappearance,
good agreementwas observed. Thus neither the surgical procedures employed nor CoF treatment
have any effect on the survival of "Cr platelets.
Complement Measurements .
￿
Plasma samples were analyzed for C3 by radial immunodiffusion
(31). Theanti-C3 antiserumwas obtained by immunizing guinea pigs with zymosanthat hadbeen
treated with normal rabbit serum and extensively washed. The area of the precipitin ring was
calculated, andchangesin C3 concentration were determined by comparingthe C3 concentration
afterinjectionto theC3 concentrationdetermined priorto LBS injection. The C3 levels determined
from the two preinjection plasma samples differed by less than 10%. In some experiments serum
wascollected, and CHsu values were determined according to Kniker and Cochrane (32).
The concentration of C6 in the serum of offspringof a C6-deficient doeand a heterozygous buck
was determined hemolytically. Aliquots of the test serum were added to C6-deficient serum and
assayed in the hemolytic complement assay (32). Pooled normal rabbit serum was used as a
standard and considered to be 100%. The heterozygous rabbits tested had between 35-45% of
normal C6 levels.
Depletion of C3 .
￿
CoF was purified by DEAE Sephadex A-50 chromatography according to
Cochrane et al. (33). Decomplementation of normal 2-2.5 kg rabbits wasaccomplished with 600-
750 U of CoF administered by four or five intraperitoneal injections of 150 U of CoFduring a36-h
period ending 24 h before thestartof the experiment. In all experiments the plasma C3 concentra-
tion, as determined by quantitative immunodiffusion techniques, was always less than 5% of the
concentrationbefore CoF injection.
Gross and Microscopic Observations .
￿
Rabbits were sacrificed for autopsy examination 24 h
after injectionof LPS or, in cases in whichrabbits failed to survive, were autopsied as close to the
time of deathas possible. Afterexamination ofthe organs macroscopically, sections were takenof
the lung, liver, spleen, and kidney routinelyalong with sections from any tissue of other organs
appearingabnormal. In initialexperiments, microscopic sections were prepared from all organs of
thebody. Sections were fixed in 10% neutralformalin forembedding in paraffin and were quickly
frozen at -70°C for fluorescent microscopic observations. Paraffin-embedded tissues were stained
with hematoxylin andeosin, phosphotungstic acid hematoxylin, and periodic acid Schiffreagent.
Frozen sections were treated with fluorescent antibodies directed to rabbit fibrinogen, gamma
globulin, C3, and albumin. As control, specific antibodies were absorbed from the antibody
solution by addition of purified antigen before treatment of the frozen sections.
Results
Hypotension Induced in Rabbits by ThreePreparations ofBacterial LPS.
￿
To
compare the various preparations of LPS used in these studies the relationshipULEVITCH, COCHRANE, HENSON, MORRISON, AND DOE
￿
1573
s0 ue 0111 :84
db 41824
" - " x8881
. . . .
. . . . . . 100 200 300
Minutes Post-injection
FIG. 1.
￿
The dependence ofblood pressure changeson the concentration ofE. coli 0111 :134
LPS. The data are expressed as a percentage of the preinjection mean arterial blood
pressure. Results for two individual animals are shown in each panel.
between dose of LPS and blood pressure fall during a 5-h period after injection
was determined for the soluble LPS preparations from E. coli 0111 :134 and S.
minnesota Re595 and the particulate LPS from S. marcescens .
Representative data from several individual animals injected with 50, 100, or
250 Wg of LPS 0111 :134 is shown in Fig. 1. Dose response experiments for both
Re595 and S. marcescens LPS were also performed to determine the minimal
concentration of these molecules which would initiate and maintain a 30%
decrease in blood pressure during a 5-h period. In most subsequent experiments
concentrations of LPS were used which produced and sustained at least a 30%
fall in mean arterial bloodpressure over 5 h, namely 100 wg for LPS0111 :134 and
S. marcescens and 50 Mg for LPS Re595. Although the minimal dose usually did
not result in death during a 24-h period all animals injected with LPS were
characterized as visiblysick. Forexample, in one series of experiments 2/12, 1/9,
and 1/6 rabbits injected with the minimal hypotensive dose of Re595, S. marces-
cens, and 0111 :134, respectively, were dead at 24 h postinjection . However, all of
the survivors in each group were characterized as sick, and as to be described in
a subsequent section, presented evidence of DIC. Animals injected with saline
demonstrated less than 10% change in mean arterial pressure during the 5 h of
the experiment (shaded areas, Figs . 2-4).
During the experiment 2.5-ml blood samples were removed. To eliminate the
possibility that the blood sampling potentiated blood pressure decreases after
LPS injection, a group of animals that were bled twice before injection and then
at 5, 30, 90, 180, and 300 min postinjection (17.5 ml blood removed) were1574 THE ROLE OF COMPLEMENT IN LPs-INDUCED HYPOTENSION
FLC. 2.
￿
Theeffect of removal of blood samples on LPS-induced hypotensive changes. Two
groups ofrabbits were injected with 100Wgof0111 :B4 LPS. Onegroup hadno blood samples
removed, while the other had 2.5-ml samples removed twice before LPS injection and at 5,
30, 90, 180, and 300 min postinjection. The numbers of animals in each group is given in
parentheses. Blood pressure changes in animals injected with saline are shown in the
shaded area.
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The effect on mean arterial blood pressure of injection of0111:B4 LPS (left panel)
andRe595 (right panel) innormal andCoF-treated rabbits. Normal rabbits were depleted of
C3 by multiple intraperitoneal injectionsof 150 U/injection of CoF. CoF-treated animals had
less than 5% of the pretreatment C3 levels at the time of LPS injection and during the
experiment. The mean arterial blood pressure in normal and CoF-treated rabbits injected
with saline is shownin the shaded area. The numbers of rabbits in each group is given in
parentheses.
compared with a group of animals that had no blood removed. The results of
experiments with 0111 :B4 LPS are shown in Fig. 2. These data indicate that
only at 30 min postinjection is there a difference between the two groups of
animals. Even when up to 35 ml of blood were removed (data not shown) the
pressure changes observed were of the same magnitude as the two groups of
experimental animals shown in Fig. 2. Other experiments (data not shown)
indicated that blood sampling had no effect on animalsinjected with Re595 or S.
marcescens LPS.
Blood Pressure Changes in CoF-Treated Rabbits.
￿
To assess the role of C3 in
LPS-induced hypotension normal rabbits were depleted of C3 and terminal
complement components by multiple intraperitoneal injections of CoF. At theULEVITCH, COCHRANE, HENSON, MORRISON, AND DOE
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The effect on mean arterial blood pressure ofinjection of 100 leg ofS. marcescens
LPS into normal and CoF-treated rabbits. CoF-treated animals had less than 596 of their
circulating C3 at the time ofinjection and during the experiment. The numbers ofrabbits in
each group is given in parentheses.
startof the experiment andduring the 5 hof measurement theplasma C3 levels
were less than 5% of the pre-CoF treatment value.
Results obtained afterthe injection of 100 Wg of 0111 :134 LPS or 50 Nkg of Re595
LPS are given in Fig. 3. Normal animals show a blood pressure fall character-
ized by an initial decrease of 25-30% within 30-60 min postinjection, no change
or a partial return in the pressure 60-120 min postinjection, and a secondary
small drop occurringbeyond 120 min postinjection. When 100 kg of 0111 :134 LPS
was injected into CoF-treated rabbits both the rate and extent of the pressure
drop was identical to that observed in normal rabbits. (Fig. 3, left panel)
Injection of 50 /Lg of Re595 into CoF-treated rabbits produced an initial decrease
in blood pressure (60 min postinjection) paralleling that in normal rabbits, but
the secondary drop in pressure wassomewhat reduced when compared to that of
normal animals (Fig. 3, right panel).
Experiments were also performed with 100 Wg ofS. marcescens . Theseresults
are shown in Fig. 4, and it is apparent that the blood pressure decreases
observed in CoF-treated rabbits parallel those seen in normal animals. In
additional experiments, 12.5 mg of S. marcescens was injected into normal and
CoF-treated rabbits (six rabbits in each group). The hypotension that resulted
was identical in the two groups and similar in intensity and time-course to that
shown in Fig. 4 with 100 Wg of the S. marcescens LPS.
Blood Pressure Changes in C6-Deficient Rabbits.
￿
Although the blood pres-
sure changes in CoF-treated rabbits parallel those observed in normal rabbits a
role forthe terminal components C5-C9 cannot be completely excluded. The low
level of C3 (5%) in CoF-treated rabbits could be sufficient to permit lysis of a
critical target cell by C5-C9. Thus participation of the terminal sequence of
complement components (C5-C9) in LPS-induced hypotension was assessed
using rabbits genetically deficient in C6. Rabbits deficient in C6 were injected1576
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(Left panel) The effect of injection of 100 wg of 0111 :134 LPS on mean arterial blood
pressure in C6-deficient rabbits andrabbits heterozygous for the C6 deficiency. The hetero-
zygotes have 35-45% of normal C6 levels. (Right panel) The effect of injection of 250 hg of
0111:134 LPS into C6-deficient rabbits compared with the effect of injection of 100 Jig of
0111:134 LPS into normal rabbits. The numbers of animals in each group is given in
parentheses.
with 100 hg of 0111:134 LPS, and the decrease in blood pressure was compared
with that observed in normal rabbits. These results are shown in Fig. 5 (left
panel). Injection of 100 jig of 0111 :134 LPS into C6-deficient rabbits induced a
decrease in blood pressure in C6-deficient rabbits over the 5-h period. Between 3
and 5 h, the hypotension was less than that observed in normal animals. This
decreased response could occur as a result of strain differences between the C6-
deficient rabbits and the normal rabbits or a participation of C5-C9 in mediat-
ing LPS-induced hypotension. To distinguish this, rabbits heterozygous for the
C6 deficiency trait (35-45% normal C6 levels) were injected with 100 wg of
0111 :134 LPS. The fall in blood pressure observed paralleled that seen with the
C6-deficient rabbits. Theseresults suggest that a strain difference could account
for the diminished response to 0111:134 in both C6-deficient and rabbits with a
partial deficiency of C6 as compared to normal rabbits. This difference would be
reflected by a different dose response behavior with respect to 0111 :134 LPS. To
test this a group of C6-deficient rabbits were injected with 250 Wg of 0111 :134.
These data are shown in Fig. 5 (right panel) . The C6-deficient rabbits showed an
early fall in mean arterial bloodpressure which approached that seen in normal
rabbits, although the maximum decrease occurred 20-30 min later. Some differ-
ence was observed in the second phase of the hypotension in which the C6-
deficient animals did not demonstrate as large a fall.
Peripheral Blood Cell Changes.
￿
The role of complement in alterations in
numbersofcirculatingplatelets, neutrophils, andmononuclearcells wasinvesti-
gated using normal, CoF-treated, and C6-deficient rabbits. These experiments
were performed for several reasons: (a) To define what cells are affected by LPS
injection and the kinetics of these changes, (b) to determine the role of comple-
ment in changes in peripheral blood cell numbers, and (c) to determine which, if
any, cell changes correlate with blood pressure decreases. Measurements wereULEVITCH, COCHRANE, HENSON, MORRISON, AND DOE
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The effect ofLPS injectionon circulating "Cr-platelets. (Left panel) The effect on
platelets of the injection of 100 ug of 0111:B4 LPS into normal and CoF-treated animals.
(Right panel) The effect on plateletsof the injection of 50 Fa.g of Re595 LPS on circulating
platelets in normal and CoF-treated rabbits . The numbers of animals in each group are
givenin parentheses . Thedashed line represents the theoretical curve for platelet turnover
based upon a tl,s of 30 h (see Materials and Methods) .
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obtained in the same experiments that monitored blood pressure changes after
LPS injection . The various cells were quantitated as described in Materials and
Methods .
Platelet Changes .
￿
Control experiments described in Materials and Methods
indicated that 51Cr-platelets behavedin a similar manner whennormal noncan-
nulated rabbits were compared with either normal or CoF-treated experimental
control animals . A t1,2 for platelet survival of approximately 30 h was deter-
mined . Preliminary experimentsdemonstrated a correlation between"Cr-plate-
let changes and changes in number of platelets determined by visual quantita-
tion of platelets in a hemocytometer .
After the injection of the different LPS preparations, two distinct patterns of
51Cr platelet disappearance were observed in normal animals . Injection of 100 jig
of0111:84 LPS into normal rabbitsproduced asmalldecrease (<10%) in circulat-
ing platelets 5 minafterinjection . Theremainingplatelets disappeared at a rate
that appeared to be only slightly more rapid than that observed in control
animals (Fig. 6, left panel) . When 100 pg of 0111:84 was injected into CoF-
treated rabbits and the results compared to normal rabbits, only a slight
reduction of the small drop observed at 5 min was noted (Fig. 6, left panel) .
When experiments were performed in C6-deficient rabbits injected with 100 pg
of 0111 :84 LPS platelet changes identical to those observed in normal rabbits
were seen .
In contrast to results obtained with 0111 :B4 LPS, injection of 50 wg of Re595
LPS into normal rabbits produced a rapid and substantial decrease in circulat-
ingplatelets (Fig. 6, right panel) at 5 min . The decrease was followed by a return
to about 80% of the preinjection value and then a secondary disappearance
phase . This secondary disappearancephase proceeded at an increased rate when
compared to that observed in control animals. CoF treatment greatly reduced1578
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The effect of LPSinjection on circulating s'Cr-platelets . (Left panel) The effect of
injection of 100 Wg of S. marcescens LPS on circulating platelets in normal andCoF-treated
rabbits. (Right panel) The effect of injection of 12.5 mg S. marcescens LPS on circulating
platelets in normal andCoF-treated rabbits. The number ofanimals in each group aregiven
in parentheses.
the initial decrease in circulatingplatelets observed after Re595 injection, while
having little effect on the rate of the secondary disappearance of the remaining
platelets.
Similarly when either 100 gg or 12.5 mg of S. marcescens was injected, a
biphasic platelet change was observed with the rapid and substantial drop in
plateletsbeingmarkedly reducedby CoF treatment(Fig. 7). At either concentra-
tion the secondary disappearance of platelets proceeded at a greater rate than
that observed in control animals. Experiments in which S. marcescens was
injected into C6-deficient rabbits also demonstrated a biphasic platelet response
(data not shown).
Two distinct patterns of platelet behavior have been noted. The injection of
0111:134 LPS was characterized by a change in circulating platelets that oc-
curred despitetreatment with CoF, while in marked contrast abiphasic platelet
change is observed after injection of Re595 or S. marcescens LPS. The initial
rapid drop observed after the injection of these LPSmoleculesis largely reduced
by prior administration of CoF to eliminate C3, while the secondary disappear-
ance of platelets remained unaffected.
Neutrophils and Mononuclear Cells.
￿
Injection of all three preparations of
LPS into normal, CoF-treated, or C6-deficient rabbits produced a rapid and
virtually complete disappearance of neutrophils followed by a gradual return
beginning about 180 min postinjection. The effects of injection of LPS 0111 :134 or
Re595 on neutrophils is shown in Fig. 8. No differences between normal and
CoF-treated rabbits were noted. A rapid fall in mononuclear cells to 10-20% of
preinjection levels was also observed after the injection of the different LPS
molecules into normal, CoF-treated, and C6-deficient rabbits. Changes in circu-
lating neutrophils and monocytes have been observed with as little as 0.1 N,g of
0111:134 LPS.
Gross and Histologic Evidence of DIC.
￿
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FIG. 8.
￿
The effect of LPS injection on levels of circulating neutrophils. (Left panel) The
effect of injection of 100 Wg of 0111 :84 LPS in normal and CoF-treated rabbits on levels of
neutrophils. (Right panel) The effect ofinjection of50 lAg ofRe595 LPS into normal and CoF-
treated rabbits on levels ofneutrophils. The numbers of animals in each group are given in
parentheses.
were performed on normal rabbits, rabbits depleted of C3, and C6-deficient
rabbitsinjected with the three typesof LPSdescribed in the experimentsabove.
Qualitatively similar changes occurred in rabbitsinjected with each type of LPS
although the quantity and severity of lesions (described below) were greater
when 501Ag Re595 LPS or 100 wg S. marcescens LPS, rather than 100 Wg 0111 :84
LPS, were injected. In the normal rabbits, at these dosages of LPS, the lungs
were reddened and occasionally hemorrhages were noted in both the lungs and
along the serosal surface of the large and small bowel. In some rabbits, yellow-
ish flecks of 1-2 mm, representing zones of coagulative necrosis, were observed
on the surface of the liver with penetration occurring several millimeters into
the cut surface. The kidneys in less than 10% of normal rabbits showed early
evidence of coagulative necrosis, but otherwise appeared normal. In rabbits
pretreated with CoF and injected with 50 Wg Re595 or 100 Ng S. marcescens,
greater severity of the DIC was observed grossly than in rabbits with the LPS
alone. Four control rabbits with CoF pretreatment only, did not show evidence
of DIC grossly. No differences were noted when normal and C6-deficient rabbits
injected with 0111 :B4 LPS compared.
Microscopically, fibrin thrombi were seen in a great majority of rabbits
injected with each LPS. The distribution and extent of thrombi in the case of
LPS Re595 is shown in Table I, and the appearance of fibrin-rich thrombi are
shown in Fig. 9. No thrombi were observed in saline controls. In the case of
normal rabbits injected with 50 Wg Re595, 8/10 showed thrombi microscopically
24 h after injection of LPS, while 15/19 rabbits injected with LPS of E. coli
0111 :84 and all rabbits injected with 100 jug S. marcescens demonstrated mi-
crothrombi of amoderate to mild degree. Increasing the dose of each LPSto over
3 mg resulted in greater severity in all cases with thrombi appearing in each
section of each organ. The thrombi stained blue with phosphotungstic acid
hematoxylin and reacted with fluorescent antifibrin but not antialbumin. IgG
and C3 were present in only small amounts in the thrombi.1580
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TABLE I
Microscopic Evaluation ofIntravascular Coagulation S. minnesota Re595 (50 fag)
Neg
* The numbers represent individual rabbits bearing lesions of the stated severity 24 h after
injection of LPS. Severe: marked numbers of thrombi in each section of tissue with evidence of
renal cortical necrosis. Moderate : occasional thrombi in each section of tissue. Mild : rare
thrombi observed in occasional sections.
Rabbits depleted of C3 and terminal components with CoF before injection
with LPS demonstrated qualitativelysimilar changesas normal rabbits, but the
lesions were more numerous and of greater severity (Table I) . Frequently with
S. marcescens (4/4) and occasionally with E. coli 0111 :134 (3/11), rabbits pre-
treated with CoF developed severe thrombotic lesions. Of four rabbits injected
with CoF alone intraperitoneally (without a second injection of LPS), one
showed a single microthrombus in the lung. In five C6-deficient rabbits, injec-
tions of 100 lig E. coli 0111 :134 produced microthrombi to an extent similar to
that in normal rabbits.
In Vivo Complement Measurements .
￿
To determinewhetherthe LPS prepara-
tions used do activate complement in vivo, plasma wasanalyzed for C3 by radial
immunodiffusion in all experiments in which blood pressure and peripheral
blood cell changes were studied. In addition, separate experiments were per-
formed in rabbits that were injected with up to 30 times the minimal hypoten-
sive dose, and serum samples were collected for CH,. determination.
Using the minimal concentration of each LPS that produced hypotension and
DIC, no changes in plasma C3 concentration were detected. These data are
shownforindividual animals in Fig. 10 (solid line), butare representative of the
22 animals tested. Only when doses 30-100 timesthe minimal hypotensive dose
were tested slight decreases in C3 were observed and are most apparent in
animals injected with Re595. Simultaneous measurement of RSA or rabbit IgG
by radial immunodiffusion revealed no changes in these proteins during the
time when the modest decrease in plasma C3 concentration was observed.
Changes in CHso measured at various times afterinjection of 3 mg 0111 :134 or
Re595 indicatedno consistent pattern ofdecrease. (Fig. 11) Even when decreases
were detected the changes were only 20-30%. Again these experiments were
performed with concentrations of LPS much greater than that required to
produce hypotension or DIC.
Hypotensive Changes Associated with Complement Activation . The pre-
vious data suggest that complement is not required for the production of LPS-
induced hypotension. The followingexperiment wasperformedto directly exam-
ine the effect ofintravascular complement activation on blood pressure changes.
Moder-
ate*
Normal rabbits
Mild Neg Severe
CoF
Mod
rabbits
Mild
Liver 3 5 3 1 2 1
Lung 2 6 3 1 1 2
Kidney 1 4 6 1 2 1
Spleen 4 5 2 1 1 2ULEVITCH, COCHRANE, HENSON, MORRISON, AND DOE
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Ftc . 9.
￿
(a) Photomicrograph of aglomerulus of arabbit injected 24 hpreviously with 50,ug
of Re595 LPS. Abundant fibrin deposits arenoted in the capillarylumens of the glomerular
tufts. Advanced necrosis of the renal parenchyma hasoccurred in this severe reaction. PAS
stain x 320 . (b)Photomicrograph of a fibrin deposit in apulmonary vessel . PASstain x 100 .1582
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FIG . 10 .
￿
The effect of LPS injectionon plasma C3 levels determined by radial immunodif-
fusion measurements. Each panel shows results obtained with individual animals injected
with 0111 :B4, Re595, orS. marcescens LPS .
FIG. 11 .
￿
The effect of LPS injection on in vivo CH50 values determined after injection of
LPS . The data is expressed as a percentage change from the preinjection value . Results for
individual animals are given in each panel .
To activate the complement system, intravenous or intraperitoneal injections of
300 U of CoF were administered to normal rabbits, and the effect of the
injections on blood pressure followed . The experimental procedure utilized in
this experiment was identical to that described for the LPS experiment except
that only CoF was administered. Blood samples were removed at various times
before and after CoF injection . Changes in plasma C3 levels were measured by
radial immunodiffusion and used to assess complement activation . The effects of
CoF injection on mean arterial blood pressure and C3 concentrations are shown
in Fig . 12 . As noted a fall in blood pressure occurred immediately after theULEVITCH, COCHRANE, HENSON, MORRISON, AND DOE
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FIG. 12.
￿
A comparison ofblood pressure changes and changes in plasma C3 levels after the
intravenous and intraperitoneal injection of 300 U of CoF. The numbers ofanimals in each
group is given in parentheses.
injection ofCoF intravenously, but not after itsinjection intraperitoneally. The
drop was short lived, withnormal blood pressure levels resumed within 30 min.
The fall was accompanied by a rapid fall of C3 levels, with a decrease of30-40%
occurring in the first few minutes after injection. The amount of C3 activated
could have been even greater, since clearance of the activated C3 from the
circulation was required to detect decreases by the immunologic technique
employed. In rabbits injected with 300 U of CoF intraperitoneally the levels of
C3 fall to approximately the same extent, but the rate offall was much slower.
In these rabbits hypotension was not observed.
Discussion
Hypotension Induced by Bacterial LPS. Its Relationship to Complement
Activation . The results suggest that C3 and terminal complementcomponents
are of minimal importance in the initiation of LPS-induced hypotension and
DIC. This conclusion is based upon experiments that compared the effect of
injection of three different LPS preparations into normal, CoF-treated, and C6-
deficient rabbits and upon experiments designed to examine the hypotension
associated with activation of complement. Depletion of C3 with CoF before
injection ofLPSfailed to prevent the hypotensionandDIC. In addition, hypoten-
Sion and DIC were observed in C6-deficient rabbits injected with LPS.
The studies were conducted with three different preparations of LPS to
maximize observation ofpotentially different effects on hypotension, DIC, and
changes in blood cells and plasma protein systems produced by LPS. The three
different LPS preparations were chosen for the following reasons: (a) LPS
0111:134 , as prepared, is soluble in aqueous solution, and in vitro was not an
efficient activator of hemolytic complement, (b) LPS Re595, although insoluble
as purified, was chemically solubilized. This molecule, in contrast to 0111:134
LPSwas a potent activator ofserum hemolytic complement, and(c) LPS fromS.
marcescens used in these studies was only partially soluble in aqueous solution
and was not a highly purified preparation. LPS from S. marcescens has been1584
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utilized by other investigators and therefore allows our studies to be compared
with previous reports .
Dose-response studies were performed to determine a minimal concentration
of LPS required to produce a 30% decrease in mean arterial blood pressure
during the 5-h period ofmeasurement . While the 30% dropwas chosen arbitrar-
ily, the use ofa threshold dose permitted the study of hypotension at a dose of
LPS that was not lethal and that would be most sensitive for experimental
manipulation of complement . No significant differences were observed in the
three LPS preparations in their ability to induce a hypotensive change in
normal rabbits . Furthermore, we established that the removal of blood samples
duringthe experiment had little effect on the hypotensive changes observed .
Changes in blood pressure observed after injection of any one of the three
preparations used could be divided into two phases . The first drop occurred
within 30-80 min of injection, and then the blood pressure was either main-
tained at this level or partially returned to normal during the subsequent hour .
A secondary smalldecrease occurred between 120 min postinjection and the final
measurement at 300 min .
The minimal importance of C3 in the establishment of the first phase of the
pressure fall is readily apparent when CoF-treated rabbits injected with 0111 :134
orS. marcescens LPS are compared with normal animals (Fig . 3 and 4) . No
differences are observed in these groups . Furthermore, the second phase of the
pressure drop was similar when normal and CoF-treated rabbits injected with
either 0111 :134 or S . marcescens are compared . Only in the group injected with
Re595 does CoF treatment produce any difference in blood pressure changes . In
this group the secondary fall in blood pressure does not occur, but the mean
arterial blood pressure is maintained at levels between 75-85% of the preinjec-
tion blood pressure . Thus with this type ofLPS it appears that C3 and terminal
complement components may play a role in the potentiation ofthe LPS-induced
blood pressure fall . Experiments in which 12.5 mg o£ S. marcescens were
injected into normal and CoF-treated rabbits also demonstrated no difference in
the LPS-induced hypotension when these two groups were compared .
Experiments with C6-deficient rabbits also provide evidence that the complete
sequence of terminal components C5-C9 is not required for LPS-induced hypo-
tension . These data indicate a minimal role for either "innocent bystander" lysis
(37) of various effector cells or direct lysis of target cells which might have LPS
bound to their surface . When 100 Wg of 0111:134 were injected into C6-deficient
rabbits the mean arterial blood pressure decreased about 15% in contrast to the
30% decrease observed in normal rabbits . When the same concentration ofLPS
was injected into rabbits that were heterozygous for C6-deficiency (35-45% of
normal C6 levels) a 15% decrease in pressure was also observed . These data
suggestthat there is a strain difference between ournormal NewZealand white
rabbits and the C6-deficient animals. Inasmuch as we used a threshold dose of
LPS determined from a dose response in normal animals this difference might
be accentuated. This argument is supportedby the result obtained when 250,ug
of 0111 :134 were injected into C6-deficient rabbits. At this concentration the
change in blood pressure after LPS injection parallels that seen in normal
animals injected with 100 fcg of 0111 :134 .ULEVITCH, COCHRANE, HENSON, MORRISON, AND DOE
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These data therefore provide evidence for a minimal role of C3 and terminal
complement components in LPS-induced hypotension. At the present time there
are still several other possible roles of complement components in LPS-induced
hypotension which cannot be excluded. First the involvement of proteolytic
enzymes from neutrophils or other cells (34) which could cleave C5 to produce
the biologically active fragment C5a cannnot be completely excluded from
experiments. However, preliminary experiments have indicated that neutrophil
depletion does not block LPS-induced hypotensive changes.3 It is also possible
that a component or components reacting with the LPS before C3PA or in the
early components of the classical pathway could be involved in LPS-induced
hypotension. However, it is clear from our measurements of complement activa-
tion in vivo that little if any complement is activated by the LPS preparations
tested even when concentrations of LPS are used which are far in excess of that
required to produce hypotension.
Hypotension Associated with Activation of Complement.
￿
The studies on
hypotension associated with the activation of complement revealed significant
differences between complement and LPS-induced hypotension. Considerable
activation of C3 (greater than 30% of that in the circulation) was required to
produce hypotension after injection of CoF. In addition, the consumption of C3
had to take place rapidly, i.e., within a 5-min period. Slower consumption of C3,
as occurred after an intraperitoneal injection of CoF, failed to induce hypoten-
sion. Furthermore, the fall in blood pressure was ephemeral, with levels return-
ing to normal within 30 min in marked contrast to LPS-induced hypotensive
changes. Studies examining the causal relationship between activation of C3
and the development of hypotension will be the subject of a later publication.
Other investigators have also studied the role of complement in LPS-induced
hypotension. One of the first studies of the role of the complement system in
LPS-induced hypotensive changes was performed by From et al . in 1970 (4).
Using CoF, these investigators depleted C3 in dogs and compared the hypoten-
sive changes observed after LPS injection into normal and CoF-treated dogs.
LPS injection into normal dogs produced an immediate fall in blood pressure
(within 2 min postinjection), a gradual return to about 60-80% of normal within
30-60 min, followed by a decrease in pressure measured over 3 h. CoF treatment
abrogated the initial rapid drop but had no effect on the secondary drop in blood
pressure. This early drop in blood pressure seen in normal, but not CoF-treated
dogs, may be analogous to the decrease in mean arterial blood pressure we
observed after intravenous CoF injection. That is, the drop is associated with
activation ofcomplement and is easily reversible, possibly due to the generation
of short lived mediators such as the anaphylotoxins. The role of complement in
LPS-induced hypotension in felines has also been studied by Kitzmiller et al . (3).
CoF treatment of felines had little effect on the hypotensive change observed
after the injection of LPS.
Recently, however, another study in dogs by Garner et al. (2) indicated that
CoF-treated dogs did not demonstrate any fall in mean arterial blood pressure
after LPS injection. Although similarly to the report of From et al. (4), these
a Ulevitch, R. J., C. G. Cochrane, P. M. Henson, and D. C. Morrison. Unpublished results.1586
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authors abrogated the initial fall in blood pressure observed after LPS injection
into dogs depleted of C3 by CoF, they also indicated that CoF treatment
abrogated any secondary fall in mean arterial pressure up to 3 h after LPS
injection. An explanation of thedifferences between this studyand theresults of
From et al. (4) is not clear at this time.
It is of interest that Johnson and Ward (35) observed a protection in normal
rabbits to the lethal effects of 200 fcg of LPS that was not shared by C6-deficient
rabbits. Lethality was measured after 48 h. He postulated that the terminal
components of complement could play a role in detoxifying LPS. The present
data indicate that the acute effects of LPS (24 h) are similar in C6-deficient and
normal rabbits, although of slightly less intensityin the former, and do notbear
on the longer term (48 h) effects. No difference in the lethal effects of the three
LPS preparations wasobserved at 24 h in the present studies, as sublethal doses
were employed.
Coagulation Associated with LPS in Normal, CoF-Treated, and C6-Deficient
Rabbits. The present studies indicate that the coagulative effects of LPS can
occur despite prior depletion of C3 and in the absence of C6. This suggests that
the active fragments C3a and C5a or the complement-mediated lysis of cells are
not essential for initiation of clotting by LPS.
It was of interest that prior treatment of the rabbits with CoF to deplete C3 if
anything enhanced the coagulative effects of LPS. This observation is being
pursued in current studies. Muller-Berghaus and Lohmann (9) have recently
demonstrated hematological changes and renal glomerular microthrombi to
occur in C6-deficient rabbits infused with LPS which were indistinguishable
from those changes observed in normal rabbits treated with LPS. These results
also suggest that the terminal complement components are not required for the
consumptive coagulopathy induced by LPS.
The Effect ofLPS on Blood Cells.
￿
Injection of all three preparations of LPS
into normal, CoF-treated, and C6-deficient rabbits produces changesin circulat-
ing neutrophils, mononuclear cells, and platelets.
The behavior of neutrophils in normal rabbits injected with the minimal
hypotensive dose of any of the three LPS molecules used in this study is
characterized by a rapid, within 5-min postinjection, and almost complete
disappearance of cells from the circulation. The neutrophil levels remain be-
tween 0-10% of the starting value for approximately 2 h and then gradually
return to the circulation reaching values of 25-50% of the initial preinjection
level by 5 h postinjection. This pattern of neutrophil disappearance andreturn is
identical in CoF-treated and C6-deficient rabbits. The pattern of the disappear-
ance and return of the mononuclear cells in normal rabbits is essentially the
same as that ofthe neutrophils. The principaldifference is that the mononuclear
cells only fall to 10-20% of the preinjection level. This same pattern of mononu-
clear cell disappearance was observed in rabbits treated with CoF and in C6-
deficient rabbits. Therefore the changes in circulating neutrophils and mononu-
clear cells appears not to require the presence of C3 or terminal complement
components. At the present time the mediation system responsible for the
disappearance of the neutrophils and mononuclear cells has not been defined.
This phenomenon appears to be different from the neutropenia followed by
neutrophilia occurringafter CoF injection as described recently by McCall et al.ULEVITCH, COCHRANE, HENSON, MORRISON, AND DOE
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(36). These investigators postulated that the neutrophil changes observed after
CoF injection were mediated by some product of complement activation.
Two distinct patterns of
51Cr-platelet behavior have been observed after LPS
injection. Injection of 100 gg 0111:114 LPS into normal and CoF-treated rabbits
produced parallel changes in circulating platelets, characterized by a gradual
decrease in platelets over a 5-h period which appeared to be slightly increased
from that observed in control animals. The behavior of platelets in C6-deficient
rabbits injected with 100 Wg of 0111:114 was indistinguishable from normal
animals. Thus it appears that neither C3 nor the terminal complement compo-
nents influence the behavior of "Cr-platelets in rabbits injected with 0111:114
LPS.
In contrast, however, are the changes in circulating platelets observed after
the injection of 50 IA.g of Re595 and 100 N,g or 12.5 mg ofS. marcescens LPS.
Injection ofeither 50 N.g ofRe595 or 100 Wg ofS. marcescens induced a biphasic
change in circulating platelets. This change is characterized by a 30-60%
decrease within 5 min, a return to 70-90% of the preinjection value by 30 min,
and a secondary disappearance ofplatelets occurringat a rate greater thanthat
observed in control animals. Injection of 12.5 mg of S. marcescens differed
primarily inthe magnitude ofthe disappearance and the extent ofthe return to
the circulation. That is, platelet levels fall rapidly to less than 25% of initial
values and only returned to 40-65% of starting levels. When Re595 or S.
marcescens was injected into CoF-treated rabbits the extent ofthe initial rapid
disappearance of platelets was greatly reduced, while little if any effect was
observed in the subsequent disappearance of platelets. Preliminary experi-
ments, in which C6-deficient rabbits were injected with S. marcescens demon-
strate the same biphasic platelet change observed in normal rabbits injected
with S. marcescens LPS. The demonstration of a C3-dependent platelet disap-
pearance after the injection of either Re595 or S. marcescens is in agreement
with published observation of Brown and Lachmann (11). These investigators
also observed a biphasic change in
51Cr-platelets after injection with 1-5 mg of
S. marcescens into normal and C6-deficient rabbits, but markedly reduced the
initial disappearance phase by depletion ofC3 with CoF.
During the initial decrease and return phase ofthe platelets a portion of the
platelets are either irreversibly sequestered or are lysed, since the level of
platelets never returns to the 100% value. Whether one or both ofthese phenom-
ena are operative is unknown at this time. However what can be concluded is
that the presence of C3 is required for this change to occur. The exact mecha-
nism of these platelet changes is also unknown but at least several possibilities
exist. They are: (a) an"immune adherence" reaction involvingthe interaction of
platelets with C3b bound to their surface (37), (b) a lytic reaction in which C567,
C8, C91yse the platelet membrane (38), (c) C3a mediated release ofother factors
that could affect platelet behavior, i.e., PAF from basophils (39), and (d) LPS-
mediated release ofADP from cells by direct or indirect mechanisms (39).
Summary
We have studied the role ofcomplement in lipopolysaccharide (LPS)-induced
hypotension and disseminated intravascular coagulation (DIC) by comparing
the effects of injection of three preparations of LPS from E. coli 0111:114, S.1588
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minnesota Re595, and S. marcescens. Injections of nonlethal doses of these LPS
preparations into normal rabbits produced decreases in mean arterial blood
pressure during a 5-h period. When rabbits treated with cobra venom factor
(CoF) to deplete C3 were injected with the various LPS preparations, mean
arterial pressures fell at a rate and extent essentially identical to that observed
in normal rabbits. Rabbits genetically deficient in C6 also demonstrated LPS-
induced hypotensive changes. Only minimal, or no changes in plasma C3 levels
or serum CHso values were detected in normal rabbits after LPS injection.
Hypotensive changes were also induced in rabbits when complement was
rapidly activated by intravenous injection of CoF. In contrast to the hypotension
inducedby LPS, the fall in arterial pressure associated with the consumption of
complement was short lived and required the rapid consumption of considerable
amounts of C3.
The occurrence of DIC noted in normal rabbits injected with each preparation
of LPS was not inhibited in either rabbits treated with cobra factor or in C6-
deficient rabbits. The DIC was most pronounced after injection of Re595 and S.
marcescens LPS.
Injection of the various LPS preparations produced a rapid disappearance of
circulating neutrophils and mononuclear cells, which occurred with the same
kinetics and to the same extent in normal, CoF-treated, and C6-deficient rab-
bits. Injection of either Re595 LPS or S. marcescens LPS produced a biphasic
disappearance of circulating"Cr-platelets. In contrast, injection of 0111 :134 LPS
affected only slightly the rate of disappearance of5'Cr-platelets. Depletion of C3
by cobra factor treatment had no effect on the disappearance of platelets in
animals injected with 0111 :134. In marked contrast cobra factor treatment
greatly reduced the initial rapid disappearance of platelets in rabbits injected
with either Re595 or S. marcescens LPS, but had no effect in the secondary
disappearance phase.
The authors would like to gratefully acknowledge Kathleen Ryan, Barbara Aiken, Jan Roser,
Janice Neshyba, and Rick Landes, all of whom provided expert technical assistance in various
phases of thisproject. We would also like to thank Gary Sandford, KarenPrescott, and GayLee for
their technical illustrations.
Received for publication 4 September 1975 .
References
1. Gilbert, R. P. 1960. Mechanisms of the hemodynamic effects of endotoxin. Physiol.
Rev . 40:245.
2. Garner, R., B. V. Chater, and D. L. Brown. 1974. The role of complement in
endotoxin shock and disseminated intravascular coagulation: experimental observa-
tions in the dog. Br. J. Haematol. 28:393.
3. Kitzmiller, J. L., W. E. Lucas, and P. F. Yelenosky. 1972. The role of complement in
feline endotoxin shock. Am. J. Obstet. Gynecol . 112:414.
4. From, A. H. L., H. Gewurz, R. P. Gruninger, R. J. Pickering, and W. W. Spink. 1970.
Complement in endotoxinshock:effect ofcomplement depletionon theearlyhypoten-
sive phase. Infect. Immun . 2:38.
5. Guenter, C. A., V. Fiorica, and L. B. Hinshaw. 1969. Cardiorespiratory and meta-
bolic responses to live E. coli and endotoxinin themonkey. J. Appl. Physiol . 26:780.ULEVITCH, COCHRANE, HENSON, MORRISON, AND DOE
￿
1589
6. Beller, F. K. 1969. The role of endotoxin in disseminated intravascular coagulation.
Thromb. Diath . Haemorrh. 36(Suppl .):125.
7. McKay, D. G. 1973. Vessel wall and thrombogenesis-endotoxin. Thromb. Diath.
Haemorrh. 29 :11.
8. Brown, D. L. 1974. Complement and coagulation. In Progress in Immunology II. L .
Brent and J . Holbrow, editors. North-Holland Publishing Company, Amsterdam.
1 :191 .
9. Muller-Berghaus, G., and E. Lohmann. 1974. The role of complement in endotoxin
induced disseminated intravascular coagulation. Studies in congenitally C6-deficient
rabbits. Br. J. Haematol. 28:403 .
10. Corrigan, J. J., and C. M. Jordan. 1970. Heparin therapy in septicemia with dissemi-
nated intravascular coagulation. N. Engl. J . Med . 283 :778.
11. Brown, D. L., and P. J. Lachmann. 1972. The behavior of complement and platelets
in lethal endotoxin shock in rabbits. Int. Arch . Allergy Appl. Immunol . 75:193.
12. Gilbert, V. E., and A. 1. Braude. 1962. Reduction in serum complement in rabbits
after injection of endotoxin. J. Exp. Med. 116:477.
13. Phillips, J. K., R. Snyderman, and S . E. Mergenhagen. 1972. Activation of comple-
ment by endotoxin: A role for y2 globulin, C1, C4, and C2 in the consumption of
terminal complement components by endotoxin coated erythrocytes. J. Immunol .
109 :334 .
14. Snyderman, R., and M. C . Pike. 1975. Interactions of complex polysaccharides with
the complement system: effect ofcalcium depletion on terminal component consump-
tion. Infect. Immun . 11 :273.
15. Mergenhagen, S. E., R. Snyderman, H. Gewurz, and H. S. Shin. 1969. Significance of
complement to the mechanism of action of endotoxin. Curr. Top. Microbiol. Immu-
nol. 50 :37.
16. McCabe, W. R. 1973. Serum complement levels in bacteremia due to gram-negative
organisms. N. Engl. J. Med. 288:21.
17. Fearon, D. T., S. Ruddy, P. H. Schur, and W. R. McCabe. 1975. Activation of the
properdin pathway of complement in patients with gram-negative bacteremia. N.
Engl . J . Med. 292:937.
18. Morrison, D. C., and C . G. Cochrane. 1974. Direct evidence for Hageman factor
(factor XII) activation by bacterial lipopolysaccharides endotoxins . J . Exp . Med.
140 :797 .
19. Henson, P. M., and C. G. Cochrane. 1969. Immunological induction of increased
vascular permeability. II. Two mechanisms ofrelease from rabbit platelets involving
complement. J. Exp. Med. 129 :167.
20. Zimmerman, T. S., C. M. Arroyave, and H. J. Muller-Eberhard. 1971. A blood
coagulation abnormality in rabbits deficient in the sixth component of complement
(C6) and its correction by purified C6. J. Exp. Med. 134 :1591.
21. Stewart, G. J., and M. J. Anderson. 1971. An ultrastructural study of endotoxin
induced damage in rabbit mesenteric arteries. Br. J. Exp. Pathol. 52:75.
22 . Evensen, S. A., and D. Shepro. 1974. DNA synthesis in rat aortic endothelium : effect
of bacterial endotoxin and trauma. Microuasc. Res. 8:90.
23 . McGrath, J. M., and G. J. Stewart. 1969. The effect of endotoxin on vascular
endothelium. J. Exp . Med. 129:833.
24. Melmon, K . C., and M. J. Cline. 1968. The interaction of leucocytes and the kinin
system. Biochem . Pharmacol. 17(Suppl.):271.
25. Rivers, R. P. A., W. E. Hathaway, and W. L. Weston. 1975. The endotoxin-induced
coagulant activity of human monocytes. Br. J. Haematol. 30 :311.
26. Gordon, S., J. C. Unkeless, and Z. A. Cohn. 1975. Induction ofmacrophageplasmino-
gen activator by endotoxin stimulation and phagocytosis. J. Exp . Med. 140:995.1590
￿
THE ROLE OF COMPLEMENT IN LPS-INDUCED HYPOTENSION
27. McCabe, W. R. 1974. Gram negative bacteremia. Adv. Intern. Med. 19:135.
28. Morrison, D. C ., and L. Leive. 1975. Fractions oflipopolysaccharide from Escherichia
coli 0111 :B4 prepared by two extraction procedures. J. Biol . Chem. 250:2911 .
29. Galanos, C ., O. Liideritz, and O. Westphal. 1969. A new method for the extraction of
R lipopolysaccharides. Eur. J. Biochem. 9:245.
30. Aster, R. H ., and J. H . Jandl. 1964. Platelet sequestration in man. I. Methods. J.
Clin. Invest. 43 :843.
31. Mancini, G. A., A. O. Carbonar, and J. F. Heremans. 1965. Immunochemical
quantitation of antigen by single radial immunodiffusion. Immunochemistry. 2 :235.
32 . Kniker, W. T., and C. G. Cochrane. 1965 . Pathogenetic factors in vascular lesions of
experimental serum sickness. J. Exp. Med. 122:83.
33. Cochrane, C. G., B. S. Aikin, and H. J. Miiller-Eberhard. 1970. Depletion of plasma
complement in vivo by a protein of cobra venom: its effect on various immunologic
reactions. J. Immunol. 105:55.
34. Ward, P. A., and J. H . Hill. 1970. C5 chemotactic fragments produced by an enzyme
in lysosomal granules of neutrophils. J. Immunol. 104 :535.
35. Johnson, K. J., and P. A. Ward. 1971 . Protective effect of C6 in rabbits treated with
bacterial endotoxin. J. Immunol. 106:1125.
36. McCall, C. E., C . R. De Chatelet, D. Brown, and P. Lachmann. 1974. New biological
activity following intravascular activation of the complement cascade. Nature
(Lond.). 249:841.
37. Henson, P. M. 1974. Complement dependent platelet and polymorphonuclear leuco-
cyte reactions. Transplant. Proc. 6:27.
38. Lachmann, P. J., and R. A. Thompson. 1970. Reactive lysis: the complement-
mediated lysis of unsensitized cells. J. Exp. Med. 131 :643.
39. Benveniste, J., P. M. Henson, and C. G. Cochrane. 1972. Leucocyte-dependent
histamine release from rabbit platelets. J. Exp. Med. 136:1356.